Results of the MRM Internal Funding Fall 2019 Competition

The MRM Network is pleased to announce the results of the Fall 2019 MRM Internal Funding Competition.

The MRM Internal Funding supports research that seeks novel forward-looking insights and discovery into a basic understanding of stem cells biology, which ultimately translate into novel technologies and regenerative medicine. It aims at facilitating the use of the numerous quality platforms built across McGill University by funding pilot research projects using these MRM-affiliated core facilities.

It is with great pleasure that we announce the 6 Awardees:

Dr. Inés Colmegna

Dr. Nicoletta Eliopoulos

  • Dr. Inés Colmegna, Division of Rheumatology, RI-MUHC for her project: Hematopoietic Stem Cells as Mediators of Trained Immunity in Chronic Systemic Inflammatory Disease involving the TCP Infection and Inflammation Core Facility.
  • Dr. Nicoletta Eliopoulos, Department of Surgery, Lady Davis Institute, for her project: Orthotopic Model of Kidney Cancer for Testing Gene-Modified Adipose Tissue Stem Cells, involving the LDI Small Animal Research Core.



Dr. Alex Gregorieff

Dr. Terry Hébert

  • Dr. Alexander Gregorieff, Department of Pathology, RI-MUCH, for his project: Single cell RNA profiling to reveal the pro-regenerative effects of parasitic worms in the intestinal epithelium, involving McGill Genome Centre – CGEn.
  • Dr. Terry Hébert, Department of Pharmacology and Therapeutics, for his project: Understanding how GNB1 mutations effects differentiation of iPSCs into cortical and dopaminergic neuronal precursor cells, involving Génome Québec.



Dr. Anastasia Nijnik

Dr. Jo Anne Stratton

  • Dr. Anastasia Nijnik, Department of Physiology, for her project: iPSC Model for the Analysis of Molecular Mechanisms of MYSM1-Deficiency Syndrome, involving the Early Drug Discovery Unit (EDDU).
  • Dr. Jo Anne Stratton, Department of Neurology and Neurosurgery, the Neuro, for her project: Using iPSCs to model human brain-CSF barrier cells, involving the Early Drug Discovery Unit (EDDU).




We would like to congratulate all the winners and participants in this competition and to extend the warmest thanks to the members of the Funding & Infrastructure Committee for their evaluation of all the applications.

Copyright © 2019 McGill Regenerative Medicine Network. All rights reserved. Website by KORSR Studio, Valérie Provost & ER5.